聯交所:一化控股(02121.HK)上市地位將於下周一起取消
聯交所宣布,由2020年3月23日上午9時起,一化控股(02121.HK)的上市地位將根據《上市規則》第6.01A條予以取消。
公司的股份自2018年8月31日起已暫停買賣。根據《上市規則》第6.01A條,若該公司未能於2020年2月29日或之前復牌,聯交所可將該公司除牌。該公司未能履行聯交所訂下的復牌指引,沒有完全遵守《上市規則》的規定,並於2020年2月29日或之前復牌。於2020年3月6日,上市委員會決定根據《上市規則》第6.01A條取消該公司股份在聯交所的上市地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.